EHRA Premium Access

Prevalence and outcomes of hypoattenuation defects and appendage patency on computed tomography after left atrial appendage closure

Congress Presentation

About the speaker

Professor Hubert Cochet

University Hospital of Bordeaux, Bordeaux (France)
4 presentations
1 follower

3 more presentations in this session

Impact of P-glycoprotein and/or CYP3A4-interacting drugs on the risk-benefit profile of NOACs in patients with atrial fibrillation: a meta-analysis

Speaker: Mr M. Grymonprez (Ghent, BE)


One-year results from the FLXibility post-approval study: final real-world clinical outcomes with a next-generation left atrial appendage closure device

Speaker: Professor T. Betts (Oxford, GB)


Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure

Speaker: Doctor A. Sabbag (Ramat Gan, IL)


Access the full session

Moderated ePosters - How to optimise stroke prevention in atrial fibrillation

Speakers: Professor H. Cochet, Mr M. Grymonprez, Professor T. Betts, Doctor A. Sabbag

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb